Clinical trial
The Use of Fibroscan to Assess Liver Fibrosis in Patients With Cardiac Pacemakers and/or Implantable Cardioverter-Defibrillators
NCT02415348 is registered in ClinicalTrials.gov with University of Saskatchewan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Use of Fibroscan to Assess Liver Fibrosis in Patients With Cardiac Pacemakers and/or Implantable Cardioverter-Defibrillators
- Lead sponsor
- University of Saskatchewan
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- April 30, 2015
- Completion date
- August 31, 2016
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.